232 related articles for article (PubMed ID: 30886734)
1. Distinct interferon signatures stratify inflammatory and dysimmune myopathies.
Rigolet M; Hou C; Baba Amer Y; Aouizerate J; Periou B; Gherardi RK; Lafuste P; Authier FJ
RMD Open; 2019; 5(1):e000811. PubMed ID: 30886734
[TBL] [Abstract][Full Text] [Related]
2. Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy.
Aouizerate J; De Antonio M; Bassez G; Gherardi RK; Berenbaum F; Guillevin L; Berezne A; Valeyre D; Maisonobe T; Dubourg O; Cosnes A; Benveniste O; Authier FJ
Acta Neuropathol Commun; 2014 Oct; 2():154. PubMed ID: 25339355
[TBL] [Abstract][Full Text] [Related]
3. From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies.
Hou C; Durrleman C; Periou B; Barnerias C; Bodemer C; Desguerre I; Quartier P; Melki I; Rice GI; Rodero MP; Charuel JL; Relaix F; Bader-Meunier B; Authier F; Gitiaux C
Arthritis Rheumatol; 2021 Jun; 73(6):1044-1052. PubMed ID: 33314705
[TBL] [Abstract][Full Text] [Related]
4. [The effect of interferon-gamma on skeletal muscle cell biology].
Hou C; Baba-Amer Y; Bencze M; Relaix F; Jérôme Authier F
Med Sci (Paris); 2018 Nov; 34 Hors série n°2():35-38. PubMed ID: 30418144
[TBL] [Abstract][Full Text] [Related]
5. Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features.
Moneta GM; Pires Marafon D; Marasco E; Rosina S; Verardo M; Fiorillo C; Minetti C; Bracci-Laudiero L; Ravelli A; De Benedetti F; Nicolai R
Arthritis Rheumatol; 2019 Jun; 71(6):1011-1021. PubMed ID: 30552836
[TBL] [Abstract][Full Text] [Related]
6. Identification of distinctive interferon gene signatures in different types of myositis.
Pinal-Fernandez I; Casal-Dominguez M; Derfoul A; Pak K; Plotz P; Miller FW; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Paik J; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
Neurology; 2019 Sep; 93(12):e1193-e1204. PubMed ID: 31434690
[TBL] [Abstract][Full Text] [Related]
7. The role of interferons type I, II and III in myositis: A review.
Bolko L; Jiang W; Tawara N; Landon-Cardinal O; Anquetil C; Benveniste O; Allenbach Y
Brain Pathol; 2021 May; 31(3):e12955. PubMed ID: 34043262
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L
Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548
[TBL] [Abstract][Full Text] [Related]
9. [Expression of interferon and its correlation with clinical features in idiopathic inflammatory myopathies].
Zu N; Wang GC
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1157-60. PubMed ID: 21756766
[TBL] [Abstract][Full Text] [Related]
10. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.
Bhattarai S; Ghannam K; Krause S; Benveniste O; Marg A; de Bruin G; Xin BT; Overkleeft HS; Spuler S; Stenzel W; Feist E
J Autoimmun; 2016 Dec; 75():118-129. PubMed ID: 27522114
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
Das L; Blumbergs PC; Manavis J; Limaye VS
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex and inflammatory cell subtype expression in inflammatory myopathies and muscular dystrophies.
Nagappa M; Nalini A; Narayanappa G
Neurol India; 2013; 61(6):614-21. PubMed ID: 24441329
[TBL] [Abstract][Full Text] [Related]
13. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders.
Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau-Junyent JM; Christopher-Stine L; Corse AM; Mammen AL
Rheumatology (Oxford); 2023 Sep; 62(9):3156-3160. PubMed ID: 36707996
[TBL] [Abstract][Full Text] [Related]
14. RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.
Suárez-Calvet X; Gallardo E; Pinal-Fernandez I; De Luna N; Lleixà C; Díaz-Manera J; Rojas-García R; Castellví I; Martínez MA; Grau JM; Selva-O'Callaghan A; Illa I
Arthritis Res Ther; 2017 Jul; 19(1):174. PubMed ID: 28738907
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.
Haq SA; Tournadre A
Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.
Englund P; Lindroos E; Nennesmo I; Klareskog L; Lundberg IE
Am J Pathol; 2001 Oct; 159(4):1263-73. PubMed ID: 11583954
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis.
Pinal-Fernandez I; Quintana A; Milisenda JC; Casal-Dominguez M; Muñoz-Braceras S; Derfoul A; Torres-Ruiz J; Pak K; Dell'Orso S; Naz F; Gutierrez-Cruz G; Milone M; Shelly S; Duque-Jaimez Y; Tobias-Baraja E; Matas-Garcia A; Garrabou G; Padrosa J; Ros J; Trallero-Araguás E; Walitt B; Christopher-Stine L; Lloyd TE; Zhao C; Swift S; Rajan A; Grau-Junyent JM; Selva-O'Callaghan A; Liewluck T; Mammen AL
Ann Rheum Dis; 2023 Jun; 82(6):829-836. PubMed ID: 36801811
[TBL] [Abstract][Full Text] [Related]
18. Interferons as components of the complex web of reactions sustaining inflammation in idiopathic inflammatory myopathies.
De Paepe B
Cytokine; 2015 Jul; 74(1):81-7. PubMed ID: 25481647
[TBL] [Abstract][Full Text] [Related]
19. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
[TBL] [Abstract][Full Text] [Related]
20. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.
Wiendl H; Lautwein A; Mitsdörffer M; Krause S; Erfurth S; Wienhold W; Morgalla M; Weber E; Overkleeft HS; Lochmüller H; Melms A; Tolosa E; Driessen C
J Neuroimmunol; 2003 May; 138(1-2):132-43. PubMed ID: 12742663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
